New hope for rare blood disorder: Long-Term study of XH-S003 underway
Disease control
ENROLLING_BY_INVITATION
This study is testing the long-term safety and effectiveness of an experimental drug called XH-S003 in people with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that can cause fatigue, blood clots, and other serious problems. About 26 people who have already ta…
Phase: NA • Sponsor: S-INFINITY Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC